Frazier & Deeter, a US-based accounting and advisory firm, has announced the appointment of Beth Lee Garner as a partner in its National Employee Benefit Plan (EBP) Audit Practice. The appointment ...

Biogen Inc. has divulged 3-β-hydroxysteroid-δ(8),δ(7)-isomerase (EBP) inhibitors reported to be useful for the treatment of autoimmune disease and multiple sclerosis.

A recognized specialist in EBP audits, she has led engagements for a wide range of plan types, including 401(k), 403(b), defined benefit, health & welfare and ESOP plans. "Beth’s deep knowledge and ...